1. Home
  2. AURA vs NL Comparison

AURA vs NL Comparison

Compare AURA & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • NL
  • Stock Information
  • Founded
  • AURA 2007
  • NL 1891
  • Country
  • AURA United States
  • NL United States
  • Employees
  • AURA N/A
  • NL N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • NL Major Chemicals
  • Sector
  • AURA Health Care
  • NL Industrials
  • Exchange
  • AURA Nasdaq
  • NL Nasdaq
  • Market Cap
  • AURA 370.1M
  • NL 362.9M
  • IPO Year
  • AURA 2021
  • NL N/A
  • Fundamental
  • Price
  • AURA $6.16
  • NL $7.14
  • Analyst Decision
  • AURA Strong Buy
  • NL Sell
  • Analyst Count
  • AURA 5
  • NL 1
  • Target Price
  • AURA $22.60
  • NL $6.00
  • AVG Volume (30 Days)
  • AURA 243.1K
  • NL 29.2K
  • Earning Date
  • AURA 05-15-2025
  • NL 05-07-2025
  • Dividend Yield
  • AURA N/A
  • NL 5.05%
  • EPS Growth
  • AURA N/A
  • NL 441.25
  • EPS
  • AURA N/A
  • NL 1.25
  • Revenue
  • AURA N/A
  • NL $148,242,000.00
  • Revenue This Year
  • AURA N/A
  • NL $15.75
  • Revenue Next Year
  • AURA N/A
  • NL $2.44
  • P/E Ratio
  • AURA N/A
  • NL $5.72
  • Revenue Growth
  • AURA N/A
  • NL N/A
  • 52 Week Low
  • AURA $4.35
  • NL $5.21
  • 52 Week High
  • AURA $12.38
  • NL $9.42
  • Technical
  • Relative Strength Index (RSI)
  • AURA 56.59
  • NL 36.06
  • Support Level
  • AURA $5.68
  • NL $7.15
  • Resistance Level
  • AURA $6.30
  • NL $7.59
  • Average True Range (ATR)
  • AURA 0.48
  • NL 0.43
  • MACD
  • AURA 0.07
  • NL -0.11
  • Stochastic Oscillator
  • AURA 88.75
  • NL 2.59

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About NL NL Industries Inc.

NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

Share on Social Networks: